Message board

An international trial, led by UZ Leuven, shows that ovarian cancer patients treated with an antibody combined with chemotherapy have a longer survival compared to patients treated with standard…

Researchers in Leuven develop a genetic test to determine in which patients a maintenance treatment with PARP inhibitors would be effective

Ovarian cancer can usually be treated effectively with platin-based treatments, but over time nearly all patients do relapse because the tumour cells become resistant. A preclinical trial led by UZ…